NorthWest Biotherapeutics Inc (NWBO)

[GoodGuyBill]

KevGee59, you side-stepped the core issue: forced delivery in a buyout scenario. Instead, you focused on current volume and liquidity stats—which won’t apply if NWBO is acquired. That’s textbook data-point deflection.

Volume ? liquidity. NWBO’s float is tightly held, and high turnover often reflects algo-driven wash trading, not genuine availability. If a buyout hits and shorts are forced to deliver, it’s not about how many shares traded—it’s about how many are actually available to buy. That’s where the potential for a squeeze lives. The real pressure comes when synthetic positions meet a hard settlement deadline—and the float isn’t loose enough to bail them out.